Recent Patents on Materials Science
Title:Patent Selections:
Volume: 9 Issue: 2
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Materials Science 2016; 9 (2) . https://dx.doi.org/10.2174/187446480902170116212433
DOI https://dx.doi.org/10.2174/187446480902170116212433 |
Print ISSN 1874-4648 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4656 |
14
Related Articles
-
Potential Therapeutic Targets for Steroid-Resistant Asthma
Current Drug Targets Reprograming Carcinoma Associated Fibroblasts by microRNAs
Current Molecular Medicine Peptimmunology: Immunogenic Peptides and Sequence Redundancy
Current Drug Discovery Technologies Anticancer Effect of Amygdalin (Vitamin B-17) on Hepatocellular Carcinoma Cell Line (HepG2) in the Presence and Absence of Zinc
Anti-Cancer Agents in Medicinal Chemistry Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry Transdermal Drug Delivery: A Step towards Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Survivin as a Prognostic/Predictive Marker and Molecular Target in Cancer Therapy
Current Medicinal Chemistry Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Current Protein & Peptide Science Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets The Mediterranean Diet and Gastrointestinal Cancers Risk
Recent Patents on Food, Nutrition & Agriculture Application of NKT Cells in Immunotherapy
Current Immunology Reviews (Discontinued) Screening and Identification of Differentially Expressed Genes Between Diabetic Nephropathy Glomerular and Normal Glomerular via Bioinformatics Technology
Combinatorial Chemistry & High Throughput Screening Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)
Current Cancer Drug Targets STAT 3 as a Target for Cancer Drug Discovery
Current Medicinal Chemistry Prognostic Value of Pre- and Posttreatment PET/CT Parameters in Patients Diagnosed with Advanced Stage NSCLC
Current Medical Imaging Regulatory Requirements for PET Radiopharmaceuticals Production: Is Automation an Answer?
Current Medical Imaging Current Gene Expression Studies in Esophageal Carcinoma
Current Genomics Cell Proliferation and Cytotoxicity Assays
Current Pharmaceutical Biotechnology Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry